- Patent Title: Pharmaceutical composition, methods for treating and uses thereof
-
Application No.: US17094037Application Date: 2020-11-10
-
Publication No.: US11666590B2Publication Date: 2023-06-06
- Inventor: Uli Christian Broedl , Odd-Erik Johansen , Eric Williams Mayoux , Nima Soleymanlou , Maximilian von Eynatten , Hans-Juergen Woerle , David Z.I. Cherney , Bruce A. Perkins
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent David L. Kershner
- Main IPC: A61K31/7048
- IPC: A61K31/7048 ; A61K45/06 ; A61K38/28 ; A61K9/20 ; A61K9/28 ; A61K31/155 ; A61K31/522
Abstract:
The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or delaying the progression of chronic kidney disease in patients, for example patients with prediabetes, type 1 or type 2 diabetes mellitus.
Public/Granted literature
- US20210228610A1 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF Public/Granted day:2021-07-29
Information query
